Interpace Diagnostics Group Inc (IDXG):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Interpace Diagnostics Group Inc (IDXG) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7378
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Interpace Diagnostics Group Inc (Interpace Diagnostics), formerly PDI Inc is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathfinder platform. It also provides ThyGenX and ThyraMIR that collectively assess the risk of benign or malignant thyroid nodules, and minimizes unnecessary surgeries. Interpace Diagnostics offers diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers. The company operates through its labs located in Pennsylvania, Pittsburgh, and New Haven, the US. Interpace Diagnostics is headquartered in Parsippany, New Jersey, the US.

Interpace Diagnostics Group Inc (IDXG) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Interpace Diagnostics Group Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Interpace Diagnostics Group Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Interpace Diagnostics Group Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
PDI Acquires MiRInform Thyroid and Pancreas Cancer Test Assets from Asuragen 10
Venture Financing 12
Interpace Diagnostics Raises USD5 Million in Venture Financing 12
Interpace Diagnostics Raises USD0.1 Million in Venture Financing 13
Partnerships 14
Interpace Diagnostics Enters into Research Agreement with Viatar CTC Solutions 14
Interpace Diagnostics Enters into Partnership Agreement with Prolias Technologies 15
Equity Offering 16
Interpace Diagnostics Plans to Raise up to USD50 Million in Public Offering of Securities 16
Interpace Diagnostics Raises up to USD4 Million in Private Placement of Shares and Warrants 17
Interpace Diagnostics Raises USD4.3 Million in Private Placement of Shares 18
Interpace Diagnostics Raises USD2 Million in Private Placement of Shares and Warrants 19
Acquisition 20
PDI Acquires RedPath Integrated Pathology for USD23 Million 20
PDI Receives Option To Acquire Molecular Diagnostics Company 22
Interpace Diagnostics Group Inc – Key Competitors 23
Interpace Diagnostics Group Inc – Key Employees 24
Interpace Diagnostics Group Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Mar 15, 2018: Interpace Diagnostics Group Announces Fourth Quarter and Full Year 2017 Financial Results 26
Legal and Regulatory 28
Jan 17, 2017: Interpace Diagnostics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement 28
Other Significant Developments 29
Dec 18, 2017: Interpace Diagnostics Announces Agreement with ARUP Laboratories 29
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Interpace Diagnostics Group Inc, Medical Equipment, Key Facts, 2017 2
Interpace Diagnostics Group Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Interpace Diagnostics Group Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Interpace Diagnostics Group Inc, Deals By Market, 2012 to YTD 2018 8
Interpace Diagnostics Group Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
PDI Acquires MiRInform Thyroid and Pancreas Cancer Test Assets from Asuragen 10
Interpace Diagnostics Raises USD5 Million in Venture Financing 12
Interpace Diagnostics Raises USD0.1 Million in Venture Financing 13
Interpace Diagnostics Enters into Research Agreement with Viatar CTC Solutions 14
Interpace Diagnostics Enters into Partnership Agreement with Prolias Technologies 15
Interpace Diagnostics Plans to Raise up to USD50 Million in Public Offering of Securities 16
Interpace Diagnostics Raises up to USD4 Million in Private Placement of Shares and Warrants 17
Interpace Diagnostics Raises USD4.3 Million in Private Placement of Shares 18
Interpace Diagnostics Raises USD2 Million in Private Placement of Shares and Warrants 19
PDI Acquires RedPath Integrated Pathology for USD23 Million 20
PDI Receives Option To Acquire Molecular Diagnostics Company 22
Interpace Diagnostics Group Inc, Key Competitors 23
Interpace Diagnostics Group Inc, Key Employees 24
Interpace Diagnostics Group Inc, Subsidiaries 25

List of Figures
Interpace Diagnostics Group Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Interpace Diagnostics Group Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Interpace Diagnostics Group Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Interpace Diagnostics Group Inc (IDXG):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • John Wood Group Plc (WG.):企業の財務・戦略的SWOT分析
    John Wood Group Plc (WG.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Aeroports de Paris SA:戦略・SWOT・企業財務分析
    Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report Summary Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Omron Healthcare Co Ltd-医療機器分野:企業M&A・提携分析
    Summary Omron Healthcare Co Ltd (Omron Healthcare), a subsidiary of Omron Corp, is a provider of medical equipment for health monitoring and therapy. The company offers blood pressure monitors, digital thermometers, body fat meters, pedometers, nebulizers, body composition monitors and electric toot …
  • NXP Semiconductors NV (NXPI):企業の財務・戦略的SWOT分析
    NXP Semiconductors NV (NXPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Neoleukin Therapeutics Inc (NLTX):企業の財務・戦略的SWOT分析
    Summary Neoleukin Therapeutics Inc (Neoleukin), formely Aquinox Pharmaceuticals Inc is a biopharmaceutical company develops next generation immunotherapies to treat immunological disorders. The company's lead drug candidate NL-201 is a combined IL-2 and IL-15 protein therapeutic used as an agonist i …
  • Aphios Corp-製薬・医療分野:企業M&A・提携分析
    Summary Aphios Corp (Aphios) is a biotechnology company that develops nanotechnology drug delivery platforms. The company provides technology platforms and enhanced therapeutics for the treatment of infectious diseases, cancers and central nervous system disorders. Its therapeutic products include Z …
  • The AES Corp:企業の発電所・SWOT分析2018
    The AES Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execu …
  • Cognizant Technology Solutions Corporation:戦略・SWOT・企業財務分析
    Cognizant Technology Solutions Corporation - Strategy, SWOT and Corporate Finance Report Summary Cognizant Technology Solutions Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Orsted AS (ORSTED):企業の財務・戦略的SWOT分析
    Orsted AS (ORSTED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Topy Industries Ltd:企業の戦略・SWOT・財務情報
    Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Genetic Technologies Ltd (GTG):企業の製品パイプライン分析
    Summary Genetic Technologies Ltd (GTG) is a molecular diagnostic company that offers testing products and services to assess sporadic breast cancer risk and colorectal cancer risk assessment. It delivers the offerings by GeneType for breast cancer tests and GeneType test for colorectal cancer. GeneT …
  • Avnet, Inc.:戦略・SWOT・企業財務分析
    Avnet, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avnet, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • SensoDetect AB:医療機器:M&Aディール及び事業提携情報
    Summary SensoDetect AB (SensoDetect) is a medical device company that provides diagnostic products. The company develops neuro physiological decision support systems for diagnostics in psychiatric health care and forensics. Its SensoDetect BERA is a test instrument based on brainstem audiometry whic …
  • Align Technology Inc (ALGN):企業の財務・戦略的SWOT分析
    Align Technology Inc (ALGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Parkland Fuel Corporation (PKI):石油・ガス:M&Aディール及び事業提携情報
    Summary Parkland Fuel Corp (Parkland) is a downstream energy company. It markets various fuel and petroleum products, including gasoline, propane, lubricants, diesel, heating oil, and other petroleum products. The company maintains a portfolio of supply relationships, storage infrastructure, and thi …
  • Graham Corp (GHM):企業の財務・戦略的SWOT分析
    Summary Graham Corp (Graham) operates as an industrial equipment company that designs and builds vacuum and heat transfer equipment. The company’s products include ejectors, surface condensers, heliflow spiral tube heat exchangers, liquid ring vacuum pumps, process condensers, desuperheaters, and mi …
  • UGI Corporation (UGI)-石油・ガス分野:企業M&A・提携分析
    Summary UGI Corporation (UGI) is a holding company providing energy products and services. Through a network of subsidiaries, the company stores, transports, distributes and markets energy products and related services. It serves as a domestic and international retail distributor of propane and buta …
  • Pharmstandard:企業の戦略的SWOT分析
    Pharmstandard - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Taiho Pharmaceutical Co Ltd:企業の戦略的SWOT分析
    Taiho Pharmaceutical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • SomaLogic Inc:企業の製品パイプライン分析
    Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆